Researchers discover atomic bomb effect results in adult-onset thyroid cancer

August 29, 2008

PHILADELPHIA - Radiation from the atomic bomb blasts in Hiroshima and Nagasaki, Japan, in 1945, likely rearranged chromosomes in some survivors who later developed papillary thyroid cancer as adults, according to Japanese researchers.

In the September 1, 2008, issue of Cancer Research, a journal of the American Association for Cancer Research, the scientists report that subjects who lived close to the blast sites, were comparably young at the time, and developed the cancer quickly once they reached adulthood, were likely to have a chromosomal rearrangement known as RET/PTC that is not very frequent in adults who develop the disease.

"Recent in vitro and in vivo studies suggest that a single genetic event in the MAP kinase-signaling pathway may be sufficient for thyroid cell transformation and tumor development," said the study's lead author, Kiyohiro Hamatani, Ph.D., laboratory chief, Department of Radiobiology and Molecular Epidemiology at the Radiation Effects Research Foundation (RERF) in Hiroshima.

"Thyroid cancer is associated with exposure to external or internal ionizing radiation.Elucidation of mechanisms of radiation-induced cancer in humans, especially early steps and pathways, has potential implications for epidemiological risk analyses, early clinical diagnosis, and chemopreventive interventions," Hamatani said.

He adds that there are several irradiated populations worldwide that have been shown to have an increase in thyroid cancer, and that children exposed to radioactive fallout from the 1986 Chernobyl nuclear power plant accident who develop papillary thyroid cancer have also been found to have RET/PTC rearrangements, although they are slightly different.

This study is part of the foundation's long running follow-up research on 120,000 atomic bomb survivors. During 1958 to 1998, the study found about 470 thyroid cancer cases of which the estimated number of excess cases attributable to radiation is 63. About 90 percent of thyroid cancer among the survivors is of the papillary type.

Hamatani and colleagues from across Japan made a comparison between adult-onset papillary thyroid cancers with RET/PTC rearrangements and those with a BRAF mutation. More than 70 percent of adult onset papillary thyroid cancer in non-exposed patients is associated with mutations in the BRAF gene.

The researchers looked at the genetic profile of cancer patients in the RERF's follow-up study--50 patients who were exposed to atomic bomb radiation and 21 patients who were not. Three factors were found to be independently associated with the development of adult-onset papillary thyroid cancer with RET/PTC rearrangements. They were greater radiation dose, shorter time elapsed since radiation exposure, and younger age at the time of the bombings, Hamatani says.

"That means that a younger person living close to the bombing site would be more likely to have adult onset thyroid cancer having RET/PTC rearrangements," he said. "This is the first time this has been shown."

The findings also suggest that in childhood papillary thyroid cancer RET/PTC rearrangements may be much less clearly associated with radiation exposure, compared with adult-onset cancer, because RET/PTC rearrangements are frequent in childhood papillary thyroid cancer patients regardless of history of radiation exposure.

The researchers do not know exactly how radiation is involved in the occurrence of RET/PTC rearrangements. "It could be either by direct DNA damage or by other pathways such as a result of radiation-induced genomic instability," Hamatani said.

American Association for Cancer Research

---

---

	Thyroid Cancer: A Guide for Patients by Douglas Van Nostrand (Author), MD (Author), FACP (Author), FACNM (Author), Leonard Wartofsky (Author), MPH (Author), MACP (Author), Gary Bloom (Author), Kanchan Kulkarni (Author), MBBA (Author), Douglas Van Nostrand (Editor), MD (Editor), FACP (Editor), FACNM (Editor), Leonard Wartofsky (Editor), MPH (Editor), MACP (Editor), Gary Bloom (Editor), Kanchan Kulkarni (Editor), MBBA (Editor) The objectives of this book are two fold: (1) to offer an understandable source of information to educate the patient who has thyroid cancer as well as the patient's family members and friends, and (2) to improve not only the patient's quality of medical care but also the patient's support from family and friends.
	Dirty Bombshell: From Thyroid Cancer Back To Fabulous! by Lorna J Brunelle (Author) A treasured read. I learned, laughed, and cried. I will pass on this remarkable resource. - Dawn Eger Rizzo, Thyroid Cancer Survivor Unflappable, witty, honest, and inspirational describe Lorna's exploration of her journey. As a survivor of kidney cancer, I was awed, captivated, and encouraged by the positive nature of Lorna's personal philosophy. - Marsha E. Bergquist, Cancer Survivor Having suffered much loss from this disease, Lorna's narrative about dealing with thyroid cancer is not only filled with useful and practical information, but was cathartic for my own repressed emotions. I laughed, I cried, and I healed. - Ellie Osborne Lorna has the innate gift of bringing light, laughter, and hope while sharing her journey with readers. I was pulled in...
	The Thyroid Cancer Book by M. Sara Rosenthal Ph.D. (Author) Now in its second edition, the only consumer book on thyroid cancer in plain language, also contains a Low Iodine Cookbook. Recommended by Johns Hopkins Thyroid Tumor Center, The Thyroid Foundation of America, The American Foundation for Thyroid Patients, The Thyroid Foundation of Canada, CancerHelpUK, and thyroid cancer patients from both Thyca and Thry'Vors.
	Everything Changes: The Insider's Guide to Cancer in Your 20's and 30's by Kairol Rosenthal (Author) "By page three of the introduction to Everything Changes, I wanted not only to devour the rest of the book, but I wanted to call Kairol up, get to know her, and (if we weren't both already married) see if I could sleep with her. Then the book got really good. It is, without doubt, the most forthright, emotionally sophisticated, and plain-old valuable book of its kind I've seen. The book defines and exemplifies what the verb 'fight' really means: to arm, prepare, and engage in sustained effort to gain a desired end. If that's your mission, this is your instruction manual." —Evan Handler, actor and author of Time On Fire and It's Only Temporary: The Good News and the Bad News of Being Alive (and a guy who got well from acute myeloid leukemia in 1985)On a shoestring budget and with tape...
	QuickFACTS Thyroid Cancer by American Cancer Society (Author) More than 200,000 men worldwide will contract thyroid cancer this year, and this book emphasizes that all patients should be well-informed decision-makers in planning their own treatment. Covering everything from risk factors to living well after cancer treatment, this pocket-sized reference provides critical questions to ask your healthcare team, is updated with the latest patient treatment guidelines, and includes an advanced dictionary of cancer-related terms.
	The Thyroid Sourcebook (5th Edition) (Sourcebooks) by M. Sara Rosenthal (Author) The classic reference guide for living with thyroid disorder--now completely revised and updated The New York Times called this book "an excellent source of information." The Thyroid Sourcebook features patient narratives; information on the complications of hypo- and hyperthyroidism, such as depression, weight gain, thyroid, eye disease, and sleep disorders; the latest on complimentary medicine; and much more.
	Practical Management of Thyroid Cancer: A Multidisciplinary Approach by Ernest L. Mazzaferri (Editor), Clive Harmer (Editor), Ujjal K. Mallick (Editor), Pat Kendall-Taylor (Editor) Written by a multidisciplinary team of experts involved in the development of standards and guidelines for its management in the USA, UK, Europe and Asia, the book contains succinct and knowledgeable summaries of the management of thyroid cancer. Every chapter describes a different aspect of care, and provides clear and detailed information about caring for patients with this group of tumors. This is an invaluable reference to health care professionals, from primary to tertiary care, involved in the management of thyroid cancer such as clinical nurse specialists, clinical psychologists, family medicine practitioners, specialists in palliative care (especially for anaplastic thyroid cancers), geneticists and surgeons, endocrinologists, oncologists, pathologists, and radiologists. ...
	Thyroid Cancer: A Comprehensive Guide to Clinical Management by Leonard Wartofsky (Editor), Douglas Van Nostrand (Editor) This massive revision of the highly acclaimed first edition presents a wealth of new information and insights on every aspect of the etiology, pathogenesis, diagnosis, initial treatment, and long-term management of all varieties of thyroid cancer. Paramount is a thorough treatment of the nuclear medical aspects of diagnosing and managing the thyroid cancer patient. This includes extensive discussion of isotopes, isotope uptake and scanning procedures, radioisodine ablation and dosimetry (with or without recombinant human TSH), stunning, octreotide and FDG-PET scanning, and various alternative imaging modalities. Additional highlights include management of the scan negative and thyroglobulin-positive patient, ultrasound of the lymph nodes, local adjuncts to therapy of metastases, low...
	The Complete Thyroid Book, Second Edition by Kenneth Ain (Author), M. Sara Rosenthal (Author) The only book you need to understand and treat your thyroid condition Combining the expertise of two pioneers in the field--world-renowned thyroid specialist Kenneth Ain, M.D., and bestselling thyroid author and bioethicist M. Sara Rosenthal, Ph.D.--The Complete Thyroid Book provides all the essential information on the diagnosis, options, and treatment of thyroid disease. Completely updated with the latest research, this book provides a comprehensive look at tests, scans, and state-of-the-art therapies and treatments for every type of thyroid condition. The Complete Thyroid Book, now revised and updated, is your source for information on: Thyroid hormone and all other medications used in thyroid treatment Thyroid disease in special populations, including...
	Thyroid Cancer by H.-J. Biersack (Editor), F. Grünwald (Editor) The emergence of novel diagnostic and therapeutic concepts calls for the publication of a new volume on thyroid cancer. This book describes all current diagnostic techniques, including FDG-PET and MRI. In recent years these modalities have documented hitherto hidden radioiodine-negative metastases, thus improving surgical therapy. The whole gamut of treatment, including surgery, radioiodine therapy, percutaneous radiation therapy and medical management, is covered. In some 10% of differentiated thyroid cancers, the well-known treatment tools of surgery and radioiodine therapy are not sufficient. New treatment modalities such as high-dose radioiodine therapy, redifferentiation therapy with retinoic acid and recombinant TSH are therefore highlighted. In a special section devoted to...